Protocol for Evaluation of Virus Inactivation Using Low-pH Treatment

Dominick Vacante; Lisa Connell-Crowley

doi:10.5731/pdajpst.2014.00969

OtherConference Proceeding - Appendix

Protocol for Evaluation of Virus Inactivation Using Low-pH Treatment

Dominick Vacante and Lisa Connell-Crowley

PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 90-97; DOI: https://doi.org/10.5731/pdajpst.2014.00969

Dominick Vacante

1Janssen Research & Development, LLC, Malvern, PA; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lisa Connell-Crowley

2Amgen Inc., Seattle, WA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 68 no. 1 90-97

DOI

https://doi.org/10.5731/pdajpst.2014.00969

PubMed

24504239

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online February 6, 2014.

Author Information

Cited By...

7 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives

Nripen Singh, Abhiram Arunkumar, Srinivas Chollangi, Zhijun George Tan, Michael Borys, Zheng Jian Li

Biotechnology and Bioengineering 2016 113 4
Stress Factors in mAb Drug Substance Production Processes: Critical Assessment of Impact on Product Quality and Control Strategy

Tapan K. Das, Linda O. Narhi, Alavattam Sreedhara, Tim Menzen, Christoph Grapentin, Danny K. Chou, Valentyn Antochshuk, Vasco Filipe

Journal of Pharmaceutical Sciences 2020 109 1
Characterization of operating parameters for XMuLV inactivation by low pH treatment

Shivanthi Chinniah, Peter Hinckley, Lisa Connell-Crowley

Biotechnology Progress 2016 32 1
Multiple functions of caprylic acid-induced impurity precipitation for process intensification in monoclonal antibody purification

Anja Trapp, Alexander Faude, Natalie Hörold, Sven Schubert, Sabine Faust, Thilo Grob, Stefan Schmidt

Journal of Biotechnology 2018 279
Integrated viral clearance strategies — reflecting on the present, projecting to the future

David J Roush

Current Opinion in Biotechnology 2018 53
Virus Reduction of Human Plasma-Derived Biological Medicines

Shahnaz Nazari, Mohammad Ali Jalili, Majid Shahabi, Mohammad Fallah Tafti, Saleh Nasiri, Mohammad Mouradi, Kamran Mousavi Hosseini

Jundishapur Journal of Natural Pharmaceutical Products 2017 12 2
Viral clearance capability of monoclonal antibody purification

Kang Cai, Jennifer Anderson, Etienne Utiger, Gisela Ferreira

Biologicals 2024 85

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 68, Issue 1

January/February 2014

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Protocol for Evaluation of Virus Inactivation Using Low-pH Treatment

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 13 + 4 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Protocol for Evaluation of Virus Inactivation Using Low-pH Treatment

Dominick Vacante, Lisa Connell-Crowley

PDA Journal of Pharmaceutical Science and Technology Jan 2014, 68 (1) 90-97; DOI: 10.5731/pdajpst.2014.00969

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Protocol for Evaluation of Virus Inactivation Using Low-pH Treatment

Dominick Vacante, Lisa Connell-Crowley

PDA Journal of Pharmaceutical Science and Technology Jan 2014, 68 (1) 90-97; DOI: 10.5731/pdajpst.2014.00969

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

The Use of Bayesian Hierarchical Logistic Regression in the Development of a Modular Viral Inactivation Claim
Viral Inactivation: Low pH and Detergent

Google Scholar

Main menu

User menu

Search

Protocol for Evaluation of Virus Inactivation Using Low-pH Treatment

Article Information

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.